BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34740324)

  • 1. The viral expression and immune status in human cancers and insights into novel biomarkers of immunotherapy.
    Chen S; Lai H; Zhao J; Chen B; Li Y; Li Y; Li Q; Zheng Q; Huang S; Zhu X
    BMC Cancer; 2021 Nov; 21(1):1183. PubMed ID: 34740324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers.
    Deng Z; Uehara T; Maeda H; Hasegawa M; Matayoshi S; Kiyuna A; Agena S; Pan X; Zhang C; Yamashita Y; Xie M; Suzuki M
    PLoS One; 2014; 9(11):e113702. PubMed ID: 25405488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
    Chen YP; Wang YQ; Lv JW; Li YQ; Chua MLK; Le QT; Lee N; Colevas AD; Seiwert T; Hayes DN; Riaz N; Vermorken JB; O'Sullivan B; He QM; Yang XJ; Tang LL; Mao YP; Sun Y; Liu N; Ma J
    Ann Oncol; 2019 Jan; 30(1):68-75. PubMed ID: 30407504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Throughput Sequence Analysis of Peripheral T-Cell Lymphomas Indicates Subtype-Specific Viral Gene Expression Patterns and Immune Cell Microenvironments.
    Nakhoul H; Lin Z; Wang X; Roberts C; Dong Y; Flemington E
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31292228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
    Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
    Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
    Chung CH; Guthrie VB; Masica DL; Tokheim C; Kang H; Richmon J; Agrawal N; Fakhry C; Quon H; Subramaniam RM; Zuo Z; Seiwert T; Chalmers ZR; Frampton GM; Ali SM; Yelensky R; Stephens PJ; Miller VA; Karchin R; Bishop JA
    Ann Oncol; 2015 Jun; 26(6):1216-1223. PubMed ID: 25712460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decline in circulating viral and human tumor markers after resection of head and neck carcinoma.
    Lopez EM; Tanner AM; Du E; Patel SN; Weiss J; Weissler MC; Hackman T; Gupta GP; Zevallos J; Elmore S; Betancourt R; Thorne L; Sheth S; Gulley ML
    Head Neck; 2021 Jan; 43(1):27-34. PubMed ID: 32860343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV)-related oral squamous cell carcinoma in Okinawa, a subtropical island, in southern Japan--simultaneously infected with human papillomavirus (HPV).
    Higa M; Kinjo T; Kamiyama K; Chinen K; Iwamasa T; Arasaki A; Sunakawa H
    Oral Oncol; 2003 Jun; 39(4):405-14. PubMed ID: 12676263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus molecular epidemiology and variants identification in head and neck squamous cell carcinoma.
    Karbalaie Niya MH; Safarnezhad Tameshkel F; Keyvani H; Esghaei M; Panahi M; Zamani F; Tabibzadeh A
    Eur J Cancer Prev; 2020 Nov; 29(6):523-530. PubMed ID: 31738221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study.
    McCormick TM; Canedo NH; Furtado YL; Silveira FA; de Lima RJ; Rosman AD; Almeida Filho GL; Carvalho Mda G
    Diagn Pathol; 2015 Jun; 10():59. PubMed ID: 26032781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
    Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
    Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus (HPV) in Chinese oropharyngeal squamous cell carcinoma (OPSCC): A strong predilection for the tonsil.
    Xu T; Shen C; Wei Y; Hu C; Wang Y; Xiang J; Sun GH; Su F; Wang Q; Lu X
    Cancer Med; 2020 Sep; 9(18):6556-6564. PubMed ID: 32717137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.
    Messerschmidt C; Obermayer B; Klinghammer K; Ochsenreither S; Treue D; Stenzinger A; Glimm H; Fröhling S; Kindler T; Brandts CH; Schulze-Osthoff K; Weichert W; Tinhofer I; Klauschen F; Keilholz U; Beule D; Rieke DT
    Int J Cancer; 2020 Oct; 147(8):2293-2302. PubMed ID: 32468570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Human Papillomavirus and Co-Infection with Epstein-Barr Virus in Oral and Oropharyngeal Squamous Cell Carcinomas.
    Makvandi M; Jalilian S; Faghihloo E; Khanizadeh S; Ramezani A; Bagheri S; Mirzaei H
    Asian Pac J Cancer Prev; 2022 Nov; 23(11):3931-3937. PubMed ID: 36444607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond Viral Infections: The Multifaceted Roles of Human Papillomavirus and Epstein-Barr Virus in Shaping the Tumor Microenvironment.
    Fernandes Q; Sher G; Prabhu KS; Kuttikrishnan S; Merhi M; Dermime S; Junejo K; Bhat AA; Uddin S
    Discov Med; 2024 Jan; 36(180):1-15. PubMed ID: 38273742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma.
    Faden DL; Ding F; Lin Y; Zhai S; Kuo F; Chan TA; Morris LG; Ferris RL
    Oral Oncol; 2019 Sep; 96():140-147. PubMed ID: 31422205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral and Clinical Oncology of Head and Neck Cancers.
    Goon P; Schürmann M; Oppel F; Shao S; Schleyer S; Pfeiffer CJ; Todt I; Brasch F; Scholtz LU; Göerner M; Sudhoff H
    Curr Oncol Rep; 2022 Jul; 24(7):929-942. PubMed ID: 35347592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation sequencing for simultaneous determination of human papillomavirus load, subtype, and associated genomic copy number changes in tumors.
    Conway C; Chalkley R; High A; Maclennan K; Berri S; Chengot P; Alsop M; Egan P; Morgan J; Taylor GR; Chester J; Sen M; Rabbitts P; Wood HM
    J Mol Diagn; 2012; 14(2):104-11. PubMed ID: 22240447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus and human papillomavirus infections and oropharyngeal squamous cell carcinomas.
    Szkaradkiewicz A; Kruk-Zagajewska A; Wal M; Jopek A; Wierzbicka M; Kuch A
    Clin Exp Med; 2002 Nov; 2(3):137-41. PubMed ID: 12447611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.